Bain Capital Life Sciences Opportunities IV, L.P. 13D and 13G filings for Olema Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-01-13 4:24 pm Sale |
2025-01-08 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Bain Capital Life Sciences Opportunities IV, L.P. | 7,095,780 9.990% |
-374,434 (-5.01%) |
Filing |
| 2024-12-11 4:30 pm Purchase |
2024-12-04 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Bain Capital Life Sciences Opportunities IV, L.P. | 7,470,214 9.990% |
7,470,214 (New Position) |
Filing |